News | October 02, 2012

Riverain Issued Patents for New Software Cancer Imaging Filters

RiverainClearRead Bone Suppression ClearRead + Detect X-Ray

October 2, 2012 — Riverain Technologies, an industry leader and innovator in proprietary image processing and machine learning technologies, announced that the United States Patent and Trademark Office (USPTO) has awarded the company broad patents for its technologies, opening the door for the company’s software to be used in wider healthcare applications and in other industries. These two new patents not only protect Riverain’s novel chest X-ray technology, which suppresses bone and calls out suspicious tissue, but also hold enormous promise for the company to bring its breakthrough software to other medical applications, including; computed tomography (CT) scans, magnetic resonance imaging (MRI) and ultrasound.

Riverain has been issued U.S. Patent 8,204,292 for its methodology to selectively remove unwanted objects, or features, within images. The technology is used in the company’s premier software, ClearRead Bone Suppression, which suppresses the ribs and clavicles in a chest X-ray image resulting in the formation of a soft tissue image of the chest. The application provides radiologists with a clearer, unobstructed view of the chest to aid in early detection of lung disease, including lung cancer. Currently employed in chest X-ray, a range of possible applications exists within other imaging modalities including CT, MRI, positron emission tomography (PET), full field digital mammography and tomosynthesis. For example, the methodology has been successfully applied to remove and equalize the tissue in the pectoral muscle in a mammography image.

Riverain’s patented feature suppression technology is ideal for use in a variety of industries outside medical as well, including military, travel, industrial and document processing applications.

In addition, Riverain was issued U.S. Patent 8,160,335 for its proprietary computer-aided diagnosis (CAD) methodology on software or hardware derived images, such as dual energy subtracted soft tissue images and/or bone suppressed images. The technology is used in the company’s ClearRead +Detect software, an application that identifies and circles potentially cancerous lung nodules on a bone-suppressed chest X-ray image, and/or images captured by modalities such as dual energy subtraction (DES). ClearRead +Detect has been clinically proven to improve the detection of 9-30mm lung nodules and allow the detection of up to one in two previously missed lung nodules.[1]

“These recently issued patents cover some of the methods and processes that give our market-leading software solutions a distinct advantage,” said Steve Worrell, Riverain’s chief technology officer. “Riverain now has an intellectual property portfolio of more than 15 issued or pending patents and welcomes inquiries regarding applications inside and outside the medical field.”

[1] Riverain Medical OnGuard FDA PMA Reader Study Results 2009

For more information: www.RiverainTechnologies.com

Related Content

Hologic and Dexalytics to Provide Athletic Body Composition Analysis at University of Minnesota
News | Bone Densitometry Systems | February 22, 2018
Hologic Inc. announced it has signed an agreement with the University of Minnesota to be the exclusive provider of...
News | PACS Accessories | February 22, 2018
The RamSoft team will showcase radiology solutions to help users cut costs and save time at the 2018 Healthcare...
ECR 2018 Spotlights Artificial Intelligence and Current Radiology Trends
News | Interventional Radiology | February 21, 2018
The European Congress of Radiology (ECR) announced the theme of its 2018 annual meeting, Feb. 28-March 4 in Vienna...
Sponsored Content | Videos | Flat Panel Displays | February 21, 2018
This 5 megapixel, high-brightness color monitor has the high-definition display necessary for breast imaging.
Barco Highlights Imaging Workflow Compliance at HIMSS18
News | Flat Panel Displays | February 21, 2018
Barco will showcase its full line of radiology and mammography display systems with online quality assurance (QA)...
Lumedx Demonstrates Advanced Analytics at HIMSS18
News | Information Technology | February 20, 2018
February 20, 2018 – LUMEDX Corporation, a top cardiovascular data intelligence company, will show off the latest in a
Logicalis White Paper Aims to Optimize Every Healthcare IT Dollar
News | Information Technology | February 20, 2018
February 20, 2018 – Digital transformation is happening in all industries, and it will happen in healthcare whether h
Agfa Introduces Improved Engage Suite for Integrated Care
News | Patient Engagement | February 16, 2018
At the 2018 Healthcare and Information Management Systems Society annual meeting (HIMSS18), Agfa HealthCare will...
Radiography Education Enrollment Shows Marginal Rise in 2017
News | Business | February 15, 2018
Directors of radiography educational programs report the number of enrolled students increased slightly in 2017, while...
Arterys Receives First FDA Clearance for Oncology Imaging Suite With Deep Learning
Technology | Artificial Intelligence | February 15, 2018
Arterys Inc. announced its fifth 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Arterys...
Overlay Init